Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

19 sept. 2017 08h00 HE | Source: Graybug Vision, Inc.

Graybug Vision Initiates Phase 1/2 Trial of GB-102 for Wet Age-related Macular Degeneration

REDWOOD CITY, CA--(Marketwired - Sep 19, 2017) - Graybug Vision, Inc., a clinical-stage, venture-held pharmaceutical company committed to developing potentially transformative therapies for...
08 août 2017 08h00 HE | Source: Graybug Vision, Inc.

Graybug Vision CEO to Participate in OIS@ASRS Conference

REDWOOD CITY, CA--(Marketwired - Aug 8, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
08 mai 2017 08h00 HE | Source: Graybug Vision, Inc.

Valerie Smith Joins Graybug Vision as VP, Global Clinical Development Operations

REDWOOD CITY, CA--(Marketwired - May 8, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
08 mai 2017 08h00 HE | Source: Graybug Vision, Inc.

Graybug Vision's Potential Once-Per-Year AMD Treatment Data Presented at ARVO 2017

REDWOOD CITY, CA--(Marketwired - May 8, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
04 avr. 2017 08h01 HE | Source: Graybug Vision, Inc.

Graybug Vision to Present at the 16th Annual Needham Healthcare Conference on April 4

REDWOOD CITY, CA--(Marketwired - Apr 4, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
03 févr. 2017 08h00 HE | Source: Graybug Vision, Inc.

Graybug Vision CEO Jeffrey Cleland Discusses Company's Prodrug Technology at Glaucoma 360 on February 3

REDWOOD CITY, CA--(Marketwired - Feb 3, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
03 janv. 2017 08h00 HE | Source: Graybug Vision, Inc.

Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer

REDWOOD CITY, CA--(Marketwired - Jan 3, 2017) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
21 nov. 2016 08h00 HE | Source: Graybug Vision, Inc.

Graybug Vision to Present at the 28th Annual Piper Jaffray Healthcare Conference

REDWOOD CITY, CA--(Marketwired - Nov 21, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
21 juin 2016 08h00 HE | Source: Graybug Vision, Inc.

Graybug Vision Expands Executive Team With Appointments of Charles P. Semba, MD, and Ward M. Peterson, PhD

REDWOOD CITY, CA--(Marketwired - Jun 21, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
04 mai 2016 15h45 HE | Source: Graybug Vision, Inc.

Graybug Vision GB-102 Toxicology/PK Study Presented at ARVO 2016

REDWOOD CITY, CA--(Marketwired - May 4, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...

Page suivante